GlassScriptPhysician profile
Martha E Gibbs
NPI 1548274582
$1,528.45
in general payments reported to CMS, 2019-2025
17 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $643 · 2023: $162 · 2024: $163 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $340.25 | 2021-2022 | |
| Abbvie INC. | $220.25 | 2022-2025 | |
| Novo Nordisk INC | $139.81 | 2022-2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $125.01 | 2022 | |
| Lilly USA, LLC | $125.00 | 2023 | Mounjaro |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $106.54 | 2021 | |
| Janssen Biotech, INC. | $87.92 | 2025 | Tremfya |
| Stryker Corporation | $58.88 | 2024 | Na |
| Takeda Pharmaceuticals U.S.A., INC. | $50.04 | 2024 | Gattex, Eohilia |
| Astrazeneca Pharmaceuticals LP | $31.59 | 2024 | Breztri |
| Merck Sharp & Dohme LLC | $22.90 | 2021-2022 | |
| Saluda Medical Americas, INC. | $22.17 | 2024 | Evoke |
| Abbott Laboratories | $20.83 | 2023 | Freestyle Libre 3 |
| Redhill Biopharma INC. | $18.43 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $17.32 | 2022 | |
| Cequr Corporation | $16.51 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Gibbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.